Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
JBMR Plus|July 17, 2023
A Phase I Randomized Trial of Once-Daily Versus Twice-Daily Recombinant Human Parathyroid Hormone (1-84) for HypoparathyroidismSteven W Ing, Richard D Finkelman, Ping He, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|July 2, 2025
Effect of Radiation Therapy on CT Attenuation of Bone in Patients with Anorectal Cancer Treated with ChemotherapyGary K Schneider, Jason A Benedict, Jennifer Matsui, et al.
Pharmacoeconomics|February 4, 2023
Cost Effectiveness Analyses of Interventions for Osteoporosis in Men: A Systematic Literature ReviewNannan Li, Charlotte Beaudart, Jane A Cauley, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 12, 2014
Inflammatory markers and risk of hip fracture in older white women: the study of osteoporotic fracturesKamil E Barbour, Li-Yung Lui, Kristine E Ensrud, et al.
Advances in Radiation Oncology|March 19, 2026
Computed Tomography Attenuation of Bone Predicts Incident Fracture in Patients With Anorectal Cancer Treated With RadiationGary K Schneider, Jason A Benedict, Jennifer Matsui, et al.
Thyroid : Official Journal of the American Thyroid Association|April 8, 2004
Can amiodarone be restarted after amiodarone-induced thyrotoxicosis?Laura E Ryan, Lewis E Braverman, David S Cooper, et al.
JBMR Plus|May 14, 2024
Open-label extension of a randomized trial investigating safety and efficacy of rhPTH(1-84) in hypoparathyroidismAliya A Khan, Lisa G Abbott, Intekhab Ahmed, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 22, 2025
Early US Real-World Treatment Patterns and Outcomes in Palopegteriparatide Treatment for Patients with HypoparathyroidismTimothy Graham, Dolores M Shoback, Lisa Abbott, et al.
The Journal of Clinical Endocrinology and Metabolism|February 28, 2024
Indolent Behavior of Malignant Bethesda III Nodules Compared to Bethesda V/VI NodulesMayumi Endo, Jing Peng, Fadi A Nabhan, et al.
BMC Endocrine Disorders|November 21, 2021
The PARADIGHM (physicians advancing disease knowledge in hypoparathyroidism) registry for patients with chronic hypoparathyroidism: study protocol and interim baseline patient characteristicsNeil Gittoes, Lars Rejnmark, Steven W Ing, et al.
Pageof 4